...
首页> 外文期刊>Bulletin of experimental biology and medicine >Mouse Lymphosarcomas Sensitive and Resistant to Cyclophosphamide Therapy: Activity of Cathepsins B, L, and D during Various Schemes of Treatment with Cyclophosphamide and SE-Glycan.
【24h】

Mouse Lymphosarcomas Sensitive and Resistant to Cyclophosphamide Therapy: Activity of Cathepsins B, L, and D during Various Schemes of Treatment with Cyclophosphamide and SE-Glycan.

机译:对环磷酰胺治疗敏感和耐药的小鼠淋巴肉瘤:在用环磷酰胺和SE-聚糖治疗的各种方案中,组织蛋白酶B,L和D的活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We measured activities of cysteine (cathepsins B and L) and aspartyl proteinases (cathepsin D) in tumor tissue of mice with sensitive and resistant lymphosarcomas. In cyclophosphamide-resistant lymphosarcoma tissue activities of cathepsins B, L, and D were lower than in cyclophosphamide-sensitive lymphosarcoma. After treatment with cyclophosphamide in high doses enzyme activities in mice with cyclophosphamide-resistant lymphosarcoma increased more significantly than in animals with cyclophosphamide-sensitive lymphosarcoma. Sulfoethylated beta-1,3-D-glycan potentiated the effect of cyclophosphamide in mice with both forms of lymphosarcoma. This drug in the lowest dose (10 mg/kg) was most effective.
机译:我们在敏感和耐药的淋巴肉瘤小鼠的肿瘤组织中测量了半胱氨酸(组织蛋白酶B和L)和天冬氨酰蛋白酶(组织蛋白酶D)的活性。在抗环磷酰胺的淋巴肉瘤中,组织蛋白酶B,L和D的组织活性低于对环磷酰胺敏感的淋巴肉瘤的组织活性。大剂量使用环磷酰胺治疗后,对环磷酰胺耐药的淋巴肉瘤的小鼠的酶活性比对环磷酰胺敏感的淋巴肉瘤的动物的酶活性显着增加。磺乙基化的β-1,3-D-聚糖增强了两种形式的淋巴肉瘤小鼠中环磷酰胺的作用。最低剂量(10 mg / kg)的这种药物最有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号